A clinical picture of pulmonary embolism revealing light-chain myeloma
نویسندگان
چکیده
منابع مشابه
A clinical picture of pulmonary embolism revealing light‐chain myeloma
We are highlighting on the particularity of a clinical picture of pulmonary embolism revealing light-chain myeloma in a 56-year-old male patient. Myeloma remains a rare affection. Even though its revelation through pulmonary embolism remains rare, it can be explained by hyperviscosity syndrome accompanying it.
متن کاملPulmonary Embolism Revealing Idiopathic Membranous Glomerulonephritis
We describe a case of a 55-year-old man who presented with pulmonary embolism and who was found to have nephrotic syndrome due to idiopathic membranous nephropathy. There are no other signs of nephrotic syndrome such as edema.
متن کاملPulmonary Embolism: A Rare Initial Manifestation of Multiple Myeloma
Multiple Myeloma usually presents with end organ damage like bone symptoms such as pain, pathologic fracture, renal dysfunction, chronic fatigue from anemia or symptoms of hypercalcemia. Although frequently associated with venous thromboembolisms, the presentation of multiple myeloma with pulmonary embolism as its initial manifestation is extremely rare. We report the case of a 60 y/o Hispanic ...
متن کاملClinical aspects of pulmonary embolism
1. Pulmonary Embolic Disease: An Overview Venous thrombolembolic disease, including deep venous thrombosis (DVT) and pulmonary embolism (PE), is an important medical condition. It is estimated that there are approximately 5 million cases of deep venous thrombosis annually in the US. At least 10% of these lead to PE, and approximately 10% of these result in death (50,000). PE is the sole or majo...
متن کاملSerum Free Light-chain Assay for the Diagnosis, Management, and Prognosis of Multiple Myeloma
In recent decades, new serum biomarkers have been developed for routine laboratory practice, such as assaying serum free light chains and more recently, assaying immunoglobulin heavy and light chain isotypes (Hevylite). In this work, we highlight the interest of new biomarkers (Hevylite Test) in the management of monoclonal gammopathies because of the technical advantages it confers and the se...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Clinical Case Reports
سال: 2017
ISSN: 2050-0904
DOI: 10.1002/ccr3.1234